Brief: Rubius Therapeutics Appoints Dannielle Appelhans As Chief Operating Officer
29/07/2021 15:39
July 29 (Reuters) - Rubius Therapeutics Inc RUBY.O :
* RUBIUS THERAPEUTICS APPOINTS DANNIELLE APPELHANS AS CHIEF
OPERATING OFFICER
* RUBIUS THERAPEUTICS - MOST RECENTLY APPELHANS SERVED AS
SENIOR
VP OF TECHNICAL OPERATIONS AND CHIEF TECHNICAL OFFICER AT
NOVARTIS GENE THERAPIES
Source text for Eikon: ID:nGNX1tTmDf
Further company coverage: RUBY.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rubius Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Apple, TCR2 Therapeutics, Silvergate Capital
Brief: Rubius Therapeutics Inc - Nasdaq Notified Co That Trading In Co's Stock Will Be Suspended Upon Opening Of Business On March 7, 2023
Brief: Rubius Therapeutics Board Of Directors Approved Plan Of Liquidation And Dissolution Of Company
Rubius Therapeutics Inc expected to post a loss of 30 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Baidu, Boeing, Microsoft